The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so god knows what else you're doing by perturbing des master all levels in cells and stuff you know so you live and learn so there's one endpoint that's getting better another endpoint that you didn't know anything about our biomarker is getting worse and it's probably doing some bad things and therein lies the sort of humility of drug development right
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.